ITI Treatment is not First-Choice Treatment in Children with Hemophilia A and Low-Responding Inhibitors: Evidence from a PedNet Study.

H Marijke van den BergMaria Elisa MancusoChristoph KönigsRoseline D'OironHelen PlatokoukiTorben Stamm MikkelsenJayashree MotwaniBeatrice NolanElena Santagostinonull null

Published in: Thrombosis and haemostasis (2020)

In children with low-responding inhibitors negative titers were reached with regular FVIII treatment irrespective of the regimen (i.e., prophylaxis or ITI).

Keyphrases

young adults
replacement therapy